Xenon Pharmaceuticals XENE Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$102.3M+2.8% | -$105.26M-15.8% | -$90.9M-7.3% | -$84.71M-30.2% | -$65.05M+1.0% | ||
| $587K-3.9% | $611K-4.7% | $641K+1.4% | $632K-4.1% | $659K-1.1% | ||
| $16.89M+19.7% | $14.12M+3.0% | $13.71M-0.1% | $13.71M+12.6% | $12.17M-10.5% | ||
| -$88.9M-9.1% | -$81.48M-13.6% | -$71.75M-11.7% | -$64.23M-4.2% | -$61.65M-13.4% | ||
| $133K-58.2% | $318K+13.2% | $281K+79.0% | $157K+265% | $43K-94.5% | ||
| -$407.28M-750% | $62.7M+62.7% | $38.53M-53.2% | $82.26M+138% | $34.51M-65.0% | ||
| $843.01M+643% | $113.54M+4,711% | $2.36M+3,531% | $65K-94.4% | $1.15M-90.5% | ||
| $346.7M+266% | $94.65M+407% | -$30.87M-265% | $18.72M+172% | -$26.06M— | ||
| -$89.03M-8.8% | -$81.8M-13.6% | -$72.03M-11.9% | -$64.39M-4.4% | -$61.7M-11.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Xenon Pharmaceuticals generate?
- Xenon Pharmaceuticals (XENE) generated -$306.4M in operating cash flow over the trailing twelve months.
- What is Xenon Pharmaceuticals's free cash flow?
- After $889.0K of capital expenditures, Xenon Pharmaceuticals's free cash flow was -$307.3M over the trailing twelve months, down 53.8% year over year.
- Where does Xenon Pharmaceuticals's cash flow data come from?
- Every line is extracted from Xenon Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.